Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
149
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Delphi Survey on the Current and Future Korean Guidelines for Isoniazid-Monoresistant Tuberculosis

Wan Seo1 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-2036-3277View further author information
ORCID Icon,
Hyung Woo Kim2 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaView further author information
,
Eung Gu Lee3 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Bucheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-4938-5912View further author information
ORCID Icon,
Tai Joon An4 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Yeouido St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-0286-2638View further author information
ORCID Icon,
Seunghoon Kim5 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, St. Vincent’s Hospital, College of Medici ne, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-0688-2783View further author information
ORCID Icon,
Yun-Jeong Jeong6 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-2009-6420View further author information
ORCID Icon,
Sang Haak Lee7 Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0001-6259-7656View further author information
ORCID Icon,
Yeonhee Park8 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaView further author information
,
Jeongha Mok9 Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of KoreaView further author information
,
Jee Youn Oh10 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-1219-0070View further author information
ORCID Icon,
Yousang Ko11 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-1703-6590View further author information
ORCID Icon,
Sun-Hyung Kim12 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of KoreaView further author information
,
Sun Jung Kwon13 Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Konyang University Hospital, Daejeon, Republic of KoreaView further author information
,
Sung Soo Jung14 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of KoreaView further author information
,
Jin Woo Kim1 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaView further author information
,
Ju Sang Kim2 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0002-4433-231XView further author information
ORCID Icon &
Jinsoo Min15 Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6091-518XView further author information
ORCID Icon show all
Pages 5233-5242 | Received 24 May 2023, Accepted 01 Aug 2023, Published online: 11 Aug 2023

References

  • Iseman MD. Tuberculosis therapy: past, present and future. Eur Respir J Suppl. 2002;20(Supplement 36):87s–94s. doi:10.1183/09031936.02.00309102
  • Dean AS, Zignol M, Cabibbe AM, et al. Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: a multicountry analysis of cross-sectional data. PLoS Med. 2020;17(1):e1003008. doi:10.1371/journal.pmed.1003008
  • World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment; 2019:120. Available from: https://www.who.int/publications/i/item/9789241550529. Accessed May 10, 2023.
  • The Korean Academy of Tuberculosis and Respiratory Disease (KATRD). Korean guidelines for tuberculosis (4th edition); 2020. Available from: https://www.lungkorea.org/bbs/index.html?code=guide&category=&gubun=&page=1&number=10303&mode=view&keyfield=&key=. Accessed May 10, 2023.
  • Choi H, Lee H, Ra SW, et al. Developing a diagnostic bundle for bronchiectasis in South Korea: a Modified Delphi Consensus Study. Tuberc Respir Dis. 2022;85(1):56–66. doi:10.4046/trd.2021.0136
  • Jones J, Hunter D. Qualitative Research: consensus methods for medical and health services research. BMJ. 1995;311(7001):376–380. doi:10.1136/bmj.311.7001.376
  • Kim HW, Min J, Choi JY, et al. Prevalence of latent tuberculosis infection among participants of the national LTBI screening program in South Korea - A problem of low coverage rate with current LTBI strategy. Front Public Health. 2022;10:1066269. doi:10.3389/fpubh.2022.1066269
  • Kim HW, Park S, Min J, et al. Hidden loss to follow-up among tuberculosis patients managed by public-private mix institutions in South Korea. Sci Rep. 2022;12(1):12362. doi:10.1038/s41598-022-16441-7
  • Kim JS, Kim YH, Lee SH, et al. Early bactericidal activity of delpazolid (LCB01-0371) in patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 2022;66(2):e0168421. doi:10.1128/aac.01684-21
  • World Health Organization. WHO operational handbook on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 2021 update; 2021:162. Available from: https://www.who.int/publications/i/item/9789240030589. Accessed May 10, 2023.
  • Lee EG, Min J, Kang JY, et al. Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study. BMC Infect Dis. 2020;20(1):446. doi:10.1186/s12879-020-05157-6
  • Bai GH, Park YK, Choi YW, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994–2004. Int J Tuberc Lung Dis. 2007;11(5):571–576.
  • Jenkins HE, Zignol M, Cohen T, Cattamanchi A. Quantifying the burden and trends of isoniazid resistant tuberculosis, 1994–2009. PLoS One. 2011;6(7):e22927. doi:10.1371/journal.pone.0022927
  • Stagg HR, Lipman MC, McHugh TD, Jenkins HE. Isoniazid-resistant tuberculosis: a cause for concern? Int J Tuberc Lung Dis. 2017;21(2):129–139. doi:10.5588/ijtld.16.0716
  • Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J. 2008;32(5):1165–1174. doi:10.1183/09031936.00061808
  • Seifert M, Catanzaro D, Catanzaro A, Rodwell TC, Mokrousov I. Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review. PLoS One. 2015;10(3):e0119628. doi:10.1371/journal.pone.0119628
  • Lee JH, Jo KW, Shim TS. Correlation between GenoType MTBDRplus assay and phenotypic susceptibility test for prothionamide in patients with genotypic isoniazid resistance. Tuberc Respir Dis. 2019;82(2):143–150. doi:10.4046/trd.2018.0027
  • Gegia M, Winters N, Benedetti A, van Soolingen D, Menzies D. Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(2):223–234. doi:10.1016/S1473-3099(16)30407-8
  • Fregonese F, Ahuja SD, Akkerman OW, et al. Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2018;6(4):265–275. doi:10.1016/S2213-2600(18)30078-X
  • Durand F, Bernuau J, Pessayre D, et al. Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology. 1995;21(4):929–932. doi:10.1002/hep.1840210407
  • Stagg HR, Bothamley GH, Davidson JA, et al. Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance. Eur Respir J. 2019;54(4):1900982. doi:10.1183/13993003.00982-2019
  • Min J, Kim HW, Kang JY, et al. Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: a multicenter cohort study. PLoS One. 2022;17(8):e0273263. doi:10.1371/journal.pone.0273263

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.